AHRQ seeks comment on acid reflux
This article was originally published in The Gray Sheet
Executive Summary
Agency for Healthcare Research and Quality is updating its 2005 report on gastroesophageal reflux disease (GERD) and is taking comments through April 15 on three key questions. First, AHRQ will examine the comparative effectiveness evidence of medical, surgical and newer forms of treatments in improving objective (such as carcinoma) and subjective outcomes (such as quality of life impact). Second, AHRQ seeks evidence supporting whether certain treatments are more effective on patient subgroups. Finally, the agency will look at adverse effects from the various therapies and whether changes in follow-up could help mitigate negative outcomes. The 2005 report on GERD treatments, the first comparative effectiveness research review released by AHRQ, found insufficient clinical data on endoscopic therapies (1"The Gray Sheet" Dec, 19, 2005)